|
[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Kooy, A., de Jager, J., Lehert, P., Bets, D., Wulffelé, M.G., Donker, A.J.M., et al. (2009) Long-Term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients with Type 2 Diabetes Mellitus. Archives of Internal Medicine, 169, 616-625. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Koritzinsky, M. (2015) Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy. International Journal of Radiation Oncology Biology Physics, 93, 454-464. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Vander Heiden, M.G., Cantley, L.C. and Thompson, C.B. (2009) Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science, 324, 1029-1033. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Vaupel, P. and Multhoff, G. (2021) Revisiting the Warburg Effect: Historical Dogma versus Current Understanding. The Journal of Physiology, 599, 1745-1757. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Pfeiffer, T., Schuster, S. and Bonhoeffer, S. (2001) Cooperation and Competition in the Evolution of ATP-Producing Pathways. Science, 292, 504-507. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Mckeehan, W. (1982) Glycolysis, Glutaminolysis and Cell Proliferation. Cell Biology International Reports, 6, 635-650. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kamarajugadda, S., Stemboroski, L., Cai, Q., Simpson, N.E., Nayak, S., Tan, M., et al. (2012) Glucose Oxidation Modulates Anoikis and Tumor Metastasis. Molecular and Cellular Biology, 32, 1893-1907. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Sonveaux, P., et al. (2009) Targeting Lactate-Fueled Respiration Selectively Kills Hypoxic Tumor Cells in Mice. Journal of Clinical Investigation, 118, 3930-3942.
|
|
[10]
|
Zhang, J., Zhang, J., Wei, Y., Li, Q. and Wang, Q. (2019) ACTL6A Regulates Follicle-Stimulating Hormone-Driven Glycolysis in Ovarian Cancer Cells via PGK1. Cell Death & Disease, 10, Article No. 811. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Sun, X., Fan, T., Sun, G., Zhou, Y., Huang, Y., Zhang, N., et al. (2022) 2-Deoxy-D-Glucose Increases the Sensitivity of Glioblastoma Cells to BCNU through the Regulation of Glycolysis, ROS and ERS Pathways: In Vitro and in Vivo Validation. Biochemical Pharmacology, 199, 115029. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Zheng, J.B., Wong, C.W., Liu, J., Luo, X., Zhou, W., Chen, Y., et al. (2022) Glucose Metabolism Inhibitor PFK-015 Combined with Immune Checkpoint Inhibitor Is an Effective Treatment Regimen in Cancer. OncoImmunology, 11, Article ID: 2079182. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Roos, J.F., Qudsi, M., Samara, A., et al. (2018) Metformin for Lung Cancer Prevention and Improved Survival: A Novel Approach. European Journal of Cancer Prevention, 28, 311-315
|
|
[14]
|
Johansson, H., Bellerba, F., Macis, D., Bertelsen, B., Guerrieri-Gonzaga, A., Aristarco, V., et al. (2024) Effect of Metformin and Lifestyle Intervention on Adipokines and Hormones in Breast Cancer Survivors: A Pooled Analysis from Two Randomized Controlled Trials. Breast Cancer Research and Treatment, 205, 49-59. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Ng, C.W., Jiang, A.A., Toh, E.M.S., Ng, C.H., Ong, Z.H., Peng, S., et al. (2020) Metformin and Colorectal Cancer: A Systematic Review, Meta-Analysis and Meta-Regression. International Journal of Colorectal Disease, 35, 1501-1512. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zaidi, S., Gandhi, J., Joshi, G., Smith, N.L. and Khan, S.A. (2019) The Anticancer Potential of Metformin on Prostate Cancer. Prostate Cancer and Prostatic Diseases, 22, 351-361. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Courtois, S., Lehours, P. and Bessède, E. (2019) The Therapeutic Potential of Metformin in Gastric Cancer. Gastric Cancer, 22, 653-662. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ma, S., Zheng, Y., Zhou, P., Xiao, Y. and Tan, H. (2016) Metformin Use Improves Survival of Diabetic Liver Cancer Patients: Systematic Review and Meta-analysis. Oncotarget, 7, 66202-66211. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Rastmanesh, R. (2021) Metformin and Malignant Tumors: Not over the Hill: A Short Comment [Letter]. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 14, 3839-3840. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Li, Y., Hu, L., Xia, Q., Yuan, Y. and Mi, Y. (2017) The Impact of Metformin Use on Survival in Kidney Cancer Patients with Diabetes: A Meta-Analysis. International Urology and Nephrology, 49, 975-981. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Liu, C., Sun, J., Xu, J., Qian, X., Hong, S., Xu, M., et al. (2022) Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients with T2DM: An Updated Meta-Analysis. Frontiers in Pharmacology, 13, Article 865988. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Ahmed, M.F., Kanaan, G. and Mostafa, J.A. (2021) The Role of Metformin in Ovarian Cancer: Does Metformin Increase Survival in Ovarian Neoplasm? Cureus, 13, e13100. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Biondani, G. and Peyron, J. (2018) Metformin, an Anti-Diabetic Drug to Target Leukemia. Frontiers in Endocrinology, 9, Article 446. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Jaune, E. and Rocchi, S. (2018) Metformin: Focus on Melanoma. Frontiers in Endocrinology, 9, Article 472. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Mu, N., Xu, T., Gao, M., Dong, M., Tang, Q., Hao, L., et al. (2020) Therapeutic Effect of Metformin in the Treatment of Endometrial Cancer (Review). Oncology Letters, 20, Article No. 156. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Mazurek, M., Litak, J., Kamieniak, P., Kulesza, B., Jonak, K., Baj, J., et al. (2020) Metformin as Potential Therapy for High-Grade Glioma. Cancers, 12, Article 210. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Ahmed, Z.S.O., Golovoy, M., Abdullah, Y., Ahmed, R.S.I. and Dou, Q.P. (2021) Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review. Recent Patents on Anti-Cancer Drug Discovery, 16, 161-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Liu, B., Fan, Z., Edgerton, S.M., Yang, X., Lind, S.E. and Thor, A.D. (2011) Potent Anti-Proliferative Effects of Metformin on Trastuzumab-Resistant Breast Cancer Cells via Inhibition of erbB2/IGF-1 Receptor Interactions. Cell Cycle, 10, 2959-2966. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Qu, C., et al. (2014) Metformin Reverses Multidrug Resistance and Epithelial-Mesenchymal Transition (EMT) via Activating AMP-Activated Protein Kinase (AMPK) in Human Breast Cancer Cells. Molecular & Cellular Biochemistry, 386, 63-71.
|
|
[30]
|
Rao, M., Gao, C., Guo, M., Law, B.Y.K. and Xu, Y. (2018) Effects of Metformin Treatment on Radiotherapy Efficacy in Patients with Cancer and Diabetes: A Systematic Review and Meta-Analysis. Cancer Management and Research, 10, 4881-4890. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Samsuri, N.A.B., Leech, M. and Marignol, L. (2017) Metformin and Improved Treatment Outcomes in Radiation Therapy—A Review. Cancer Treatment Reviews, 55, 150-162. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Leng, W., Pu, D., Jiang, J., Lei, X., Wu, Q. and Chen, B. (2021) Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 14, 4423-4432. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Higurashi, T., Hosono, K., Takahashi, H., Komiya, Y., Umezawa, S., Sakai, E., et al. (2016) Metformin for Chemoprevention of Metachronous Colorectal Adenoma or Polyps in Post-Polypectomy Patients without Diabetes: A Multicentre Double-Blind, Placebo-Controlled, Randomised Phase 3 Trial. The Lancet Oncology, 17, 475-483. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Kim, H.J., Lee, S., Chun, K.H., Jeon, J.Y., Han, S.J., Kim, D.J., et al. (2018) Metformin Reduces the Risk of Cancer in Patients with Type 2 Diabetes: An Analysis Based on the Korean National Diabetes Program Cohort. Medicine, 97, e0036. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Sonnenblick, A., Agbor-Tarh, D., Bradbury, I., Di Cosimo, S., Azim, H.A., Fumagalli, D., et al. (2017) Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients with Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis from the ALTTO Phase III Randomized Trial. Journal of Clinical Oncology, 35, 1421-1429. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Landman, G.W.D., Kleefstra, N., van Hateren, K.J.J., Groenier, K.H., Gans, R.O.B. and Bilo, H.J.G. (2009) Metformin Associated with Lower Cancer Mortality in Type 2 Diabetes. Diabetes Care, 33, 322-326. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Wan, G., Sun, X., Li, F., Wang, X., Li, C., Li, H., et al. (2018) Survival Benefit of Metformin Adjuvant Treatment for Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis. Cellular Physiology and Biochemistry, 49, 837-847. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Everatt, R., Kuzmickienė, I., Brasiūnienė, B., Vincerževskienė, I., Intaitė, B., Cicėnas, S., et al. (2024) Evaluation of Antihypertensive Medications Use and Survival in Patients with Ovarian Cancer: A Population-Based Retrospective Cohort Study. BMC Women’s Health, 24, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Papadakos, S.P., Argyrou, A., Lekakis, V., Arvanitakis, K., Kalisperati, P., Stergiou, I.E., et al. (2024) Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights. International Journal of Molecular Sciences, 25, Article 2978. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Vazquez-Martin, A., Oliveras-Ferraros, C., Barco, S.D., Martin-Castillo, B. and Menendez, J.A. (2010) The Anti-Diabetic Drug Metformin Suppresses Self-Renewal and Proliferation of Trastuzumab-Resistant Tumor-Initiating Breast Cancer Stem Cells. Breast Cancer Research and Treatment, 126, 355-364. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Goodwin, P.J., Chen, B.E., Gelmon, K.A., Whelan, T.J., Ennis, M., Lemieux, J., et al. (2022) Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients with Breast Cancer: The MA32 Randomized Clinical Trial. JAMA, 327, 1963-1973. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Salani, B., Del Rio, A., Marini, C., et al. (2014) Metformin, Cancer Andglucose Metabolism. Endocrine-Related Cancer, 21, R461-R471.
|
|
[43]
|
Song, J., Jiang, G., Zhang, J., Guo, J., Li, Z., Hao, K., et al. (2019) Metformin Prolongs Lifespan through Remodeling the Energy Distribution Strategy in Silkworm, Bombyx Mori. Aging, 11, 240-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Song, I., Han, J. and Lee, H.K. (2014) Metformin as an Anticancer Drug: A Commentary on the Metabolic Determinants of Cancer Cell Sensitivity to Glucose Limitation and Biguanides. Journal of Diabetes Investigation, 6, 516-518. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Marsin, A., Bertrand, L., Rider, M.H., Deprez, J., Beauloye, C., Vincent, M.F., et al. (2000) Phosphorylation and Activation of Heart PFK-2 by AMPK Has a Role in the Stimulation of Glycolysis during Ischaemia. Current Biology, 10, 1247-1255. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., et al. (2013) AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth in Vivo. Cell Metabolism, 17, 113-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Schwab, L.P., Peacock, D.L., Majumdar, D., Ingels, J.F., Jensen, L.C., Smith, K.D., et al. (2012) Hypoxia-Inducible Factor 1α Promotes Primary Tumor Growth and Tumor-Initiating Cell Activity in Breast Cancer. Breast Cancer Research, 14, Article No. R6. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Cesário, J.M.S., Brito, R.B.O., Malta, C.S., Silva, C.S., Matos, Y.S.T., Kunz, T.C.M., et al. (2016) A Simple Method to Induce Hypoxia-Induced Vascular Endothelial Growth Factor-A (VEGF-A) Expression in T24 Human Bladder Cancer Cells. In Vitro Cellular & Developmental Biology—Animal, 53, 272-276. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Shackelford, D.B., Vasquez, D.S., Corbeil, J., Wu, S., Leblanc, M., Wu, C., et al. (2009) mTOR and HIF-1α-Mediated Tumor Metabolism in an LKB1 Mouse Model of Peutz-Jeghers Syndrome. Proceedings of the National Academy of Sciences of the United States of America, 106, 11137-11142. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Tyszka-Czochara, M., Bukowska-Strakova, K., Kocemba-Pilarczyk, K.A. and Majka, M. (2018) Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis While Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines. Nutrients, 10, Article 841. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Alves, M.G., Martins, A.D., Vaz, C.V., Correia, S., Moreira, P.I., Oliveira, P.F., et al. (2014) Metformin and Male Reproduction: Effects on Sertoli Cell Metabolism. British Journal of Pharmacology, 171, 1033-1042. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Cohen, B.D., Baker, D.A., Soderstrom, C., Tkalcevic, G., Rossi, A.M., Miller, P.E., et al. (2005) Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti-Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751, 871. Clinical Cancer Research, 11, 2063-2073. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Han, B., Cui, H., Kang, L., Zhang, X., Jin, Z., Lu, L., et al. (2015) Metformin Inhibits Thyroid Cancer Cell Growth, Migration, and EMT through the mTOR Pathway. Tumor Biology, 36, 6295-6304. [Google Scholar] [CrossRef] [PubMed]
|